Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Colorectal Neoplasms

Free Subscription Articles published in J Pathol Retrieve available abstracts of 27 articles: HTML format

Single Articles

November 2023
1. CHALLONER BR, Woolston A, Lau D, Buzzetti M, et al
   Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
   J Pathol. 2023 Nov 15. doi: 10.1002/path.6228.
   PubMed     Abstract available
   
   
   October 2023
2. BROUWER NP, Webbink L, Haddad TS, Rutgers N, et al
   Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer.
   J Pathol. 2023 Oct 4. doi: 10.1002/path.6196.
   PubMed     Abstract available
   
   
   
3. FEAKINS RM, Loughrey MB, Silver A
   Buds, clusters, and transitions in 21st century colorectal carcinoma: revolution or reinvention?(dagger).
   J Pathol. 2023;261:121-124.
   PubMed     Abstract available
   
   
   September 2023
4. VAN DE WEERD S, Torang A, Zwager LW, Koelink PJ, et al
   Consensus molecular subtype transition during progression of colorectal cancer.
   J Pathol. 2023 Sep 8. doi: 10.1002/path.6176.
   PubMed     Abstract available
   
   
   August 2023
5. PAGE DB, Broeckx G, Jahangir CA, Verbandt S, et al
   Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
   J Pathol. 2023 Aug 23. doi: 10.1002/path.6165.
   PubMed     Abstract available
   
   
   February 2023
6. CAI H, Feng X, Yin R, Zhao Y, et al
   MIST: multiple instance learning network based on Swin Transformer for whole slide image classification of colorectal adenomas.
   J Pathol. 2023;259:125-135.
   PubMed     Abstract available
   
   
   January 2023
7. PETROPOULOS M, Champeris Tsaniras S, Nikou S, Maxouri S, et al
   Cdt1 overexpression drives colorectal carcinogenesis through origin overlicensing and DNA damage.
   J Pathol. 2023;259:10-20.
   PubMed     Abstract available
   
   
   December 2022
8. WANG W, Zhu X, Zhang X, Lei C, et al
   Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
   J Pathol. 2022 Dec 27. doi: 10.1002/path.6047.
   PubMed     Abstract available
   
   
   November 2022
9. ZHANG J, Chen B, Li H, Wang Y, et al
   Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
   J Pathol. 2022 Nov 14. doi: 10.1002/path.6033.
   PubMed     Abstract available
   
   
   August 2022
10. PAVLIC A, Bostjancic E, Kavalar R, Ilijevec B, et al
    Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.
    J Pathol. 2022 Aug 6. doi: 10.1002/path.5998.
    PubMed     Abstract available
    
    
    July 2022
11. GLAIRE MA, Ryan NA, Ijsselsteijn ME, Kedzierska K, et al
    Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
    J Pathol. 2022;257:340-351.
    PubMed     Abstract available
    
    
    June 2022
12. KLAPHOLZ M, Drage MG, Srivastava A, Anderson AC, et al
    Presence of Tim3(+) and PD-1(+) CD8(+) T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and distinct clinicopathological features.
    J Pathol. 2022;257:186-197.
    PubMed     Abstract available
    
    
    May 2022
13. KUMAR N, Verma R, Chen C, Lu C, et al
    Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors.
    J Pathol. 2022;257:17-28.
    PubMed     Abstract available
    
    
    April 2022
14. BOSCH TVD, Miedema DM, Vermeulen L
    Copy-number heterogeneity as high-risk feature of stage II colon cancer.
    J Pathol. 2022 Apr 26. doi: 10.1002/path.5919.
    PubMed     Abstract available
    
    
    
15. HEINZE K, Nazeran TM, Lee S, Kramer P, et al
    Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8(+) TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
    J Pathol. 2022;256:388-401.
    PubMed     Abstract available
    
    
    February 2022
16. BLEIJENBERG AGC, IJspeert JEG, Mulder JBG, Drillenburg P, et al
    The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.
    J Pathol. 2022 Feb 10. doi: 10.1002/path.5881.
    PubMed     Abstract available
    
    
    January 2022
17. LAHOZ S, Archilla I, Asensio E, Hernandez-Illan E, et al
    Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer.
    J Pathol. 2022 Jan 23. doi: 10.1002/path.5870.
    PubMed     Abstract available
    
    
    
18. YAMAMOTO D, Oshima H, Wang D, Takeda H, et al
    Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    J Pathol. 2022 Jan 17. doi: 10.1002/path.5868.
    PubMed     Abstract available
    
    
    
19. SCHRAMMEN PL, Ghaffari Laleh N, Echle A, Truhn D, et al
    Weakly supervised annotation-free cancer detection and prediction of genotype in routine histopathology.
    J Pathol. 2022;256:50-60.
    PubMed     Abstract available
    
    
    December 2021
20. STEHR AM, Wang G, Demmler R, Stemmler MP, et al
    Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer.
    J Pathol. 2021 Dec 23. doi: 10.1002/path.5860.
    PubMed     Abstract available
    
    
    
21. CHARLES CAMPBELL F
    Untangling the complexities of micropapillary cancer(dagger).
    J Pathol. 2021;255:343-345.
    PubMed     Abstract available
    
    
    
22. CERRETELLI G, Zhou Y, Muller MF, Adams DJ, et al
    Ethanol-induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome.
    J Pathol. 2021;255:464-474.
    PubMed     Abstract available
    
    
    
23. KIM JH, Hong JH, Choi YL, Lee JA, et al
    NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    J Pathol. 2021;255:399-411.
    PubMed     Abstract available
    
    
    November 2021
24. BROCKMOELLER S, Echle A, Laleh NG, Eiholm S, et al
    Deep Learning identifies inflamed fat as a risk factor for lymph node metastasis in early colorectal cancer.
    J Pathol. 2021 Nov 5. doi: 10.1002/path.5831.
    PubMed     Abstract available
    
    
    October 2021
25. OHSHIMA K, Oi R, Nojima S, Morii E, et al
    Mitochondria govern histone acetylation in colorectal cancer.
    J Pathol. 2021 Oct 26. doi: 10.1002/path.5818.
    PubMed     Abstract available
    
    
    September 2021
26. ONUMA K, Sato Y, Okuyama H, Uematsu H, et al
    Aberrant activation of Rho/ROCK signaling in impaired polarity switching of colorectal micropapillary carcinoma.
    J Pathol. 2021;255:84-94.
    PubMed     Abstract available
    
    
    May 2021
27. KRAUSE J, Grabsch HI, Kloor M, Jendrusch M, et al
    Deep learning detects genetic alterations in cancer histology generated by adversarial networks.
    J Pathol. 2021;254:70-79.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.